Hematology / Oncology / Cancer Center / Breast Clinic

Research Output 1981 2019

Filter
Article
2019

A care process model to deliver177Lu-DOTATATE peptide receptor radionuclide therapy for patients with neuroendocrine tumors

Kasi, P. M., Maige, C. L., Shahjehan, F., Rodgers, J. M., Aloszka, D. L., Ritter, A., Andrus, M. L., Mcmillan, J. M., Mody, K., Sharma, A. & Jain, M. K., Jan 1 2019, In : Frontiers in Oncology. 9, JAN, 663.

Research output: Contribution to journalArticle

Open Access
Somatostatin Receptors
Peptide Receptors
Neuroendocrine Tumors
Radioisotopes
Therapeutics
12 Citations (Scopus)

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients

Lambertini, M., Campbell, C., Bines, J., Korde, L. A., Izquierdo, M., Fumagalli, D., Del Mastro, L., Ignatiadis, M., Pritchard, K., Wolff, A. C., Jackisch, C., Lang, I., Untch, M., Smith, I., Boyle, F., Xu, B., Barrios, C. H., Baselga, J., Moreno Aspitia, A., Piccart, M. & 2 others, Gelber, R. D. & de Azambuja, E., Jan 1 2019, In : Journal of the National Cancer Institute. 111, 1, p. 86-94 9 p.

Research output: Contribution to journalArticle

Amenorrhea
Breast Neoplasms
Survival
Hormones
Therapeutics

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

Ustun, C., Le-Rademacher, J., Wang, H. L., Othus, M., Sun, Z., Major, B., Zhang, M. J., Storrick, E., Lafky, J. M., Chow, S., Mrózek, K., Attar, E. C., Nand, S., Bloomfield, C. D., Cripe, L. D., Tallman, M. S., Appelbaum, F., Larson, R. A., Marcucci, G., Roboz, G. J. & 12 others, Uy, G. L., Stone, R. M., Jatoi, A., Shea, T. C., de Lima, M., Foran, J. M., Sandmaier, B. M., Litzow, M. R., Erba, H. P., Hurria, A., Weisdorf, D. J. & Artz, A. S., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Open Access
Consolidation Chemotherapy
Cell Transplantation
Acute Myeloid Leukemia
Drug Therapy
Survival

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

Dudenkov, T. M., Liu, D., Cairns, J., Devarajan, S., Zhuang, Y., Ingle, J. N., Buzdar, A. U., Robson, M. E., Kubo, M., Batzler, A., Barman, P., Jenkins, G. D., Carlson, E. E., Goetz, M. P., Northfelt, D. W., Moreno Aspitia, A., Desta, Z., Reid, J. M., Kalari, K. R., Wang, L. M. & 1 others, Weinshilboum, R. M., Jan 1 2019, In : Clinical pharmacology and therapeutics.

Research output: Contribution to journalArticle

Open Access
Aromatase Inhibitors
Genome-Wide Association Study
Single Nucleotide Polymorphism
Pharmaceutical Preparations
Breast Neoplasms
1 Citation (Scopus)

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas

Jones, R. L., Chawla, S. P., Attia, S., Schöffski, P., Gelderblom, H., Chmielowski, B., Le Cesne, A., Van Tine, B. A., Trent, J. C., Patel, S., Wagner, A. J., Chugh, R., Heyburn, J. W., Weil, S. C., Wang, W., Viele, K. & Maki, R. G., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Open Access
docetaxel
gemcitabine
Sarcoma
Confidence Intervals
Safety

Autologous Stem Cell Transplantation in Central Nervous System Lymphoma: A Multicenter Retrospective Series and a Review of the Literature

Dholaria, B. R., Kumar, A., Azzuqua, A. G., Nishihori, T., Kharfan-Dabaja, M. A., Tun, H. W. & Ayala, E., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Lymphoma
Central Nervous System
Confidence Intervals
Recurrence

Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

Vera, J., Paludo, J., Kottschade, L., Brandt, J., Yan, Y., Block, M. S., Mc Williams, R. R., Dronca, R. S., Loprinzi, C. L., Grothey, A. F. & Markovic, S. N., Jan 1 2019, In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Colchicine
Fever
Mitogen-Activated Protein Kinases
Familial Mediterranean Fever
Therapeutics
3 Citations (Scopus)

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Ma, S., Malek, S. & 9 others, Mato, A., Mosse, C., Neppalli, V. T., Shadman, M., Siddiqi, T., Stephens, D., Wagner, N., Dwyer, M. A. & Sundar, H., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 1, p. 12-20 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Lymphoma, Large B-Cell, Diffuse
Hodgkin Disease
Lymphoma
Guidelines

Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies

Gaillard, S. L., Andreano, K. J., Gay, L. M., Steiner, M., Jorgensen, M. S., Davidson, B. A., Havrilesky, L. J., Alvarez Secord, A., Valea, F. A., Colon-Otero, G., Zajchowski, D. A., Chang, C. Y., McDonnell, D. P., Berchuck, A. & Elvin, J. A., Jan 1 2019, In : Gynecologic oncology.

Research output: Contribution to journalArticle

Estrogen Receptors
Mutation
Neoplasms
Therapeutics
Aromatase Inhibitors

Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma

Ailawadhi, S., DerSarkissian, M., Duh, M. S., Lafeuille, M. H., Posner, G., Ralston, S., Zagadailov, E., Ba-Mancini, A. & Rifkin, R., Jan 1 2019, In : Clinical therapeutics.

Research output: Contribution to journalArticle

Multiple Myeloma
Costs and Cost Analysis
Therapeutics
Dexamethasone
Subcutaneous Infusions

Depomedroxyprogesterone acetate therapy for hot flashes in survivors of breast cancer: no unfavorable impact on recurrence and survival

Ertz-Archambault, N. M., Rogoff, L. B., Kosiorek, H. E., Ernst, B., Anderson, K. S., Pockaj, B. A., Gray, R. J. & Northfelt, D. W., Jan 1 2019, (Accepted/In press) In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Hot Flashes
Medroxyprogesterone Acetate
Survivors
Acetates
Breast Neoplasms

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial

Lambertini, M., Campbell, C., Gelber, R. D., Viale, G., McCullough, A., Hilbers, F., Korde, L. A., Werner, O., Chumsri, S., Jackisch, C., Wolff, A. C., Vaz-Luis, I., Ferreira, A. R., Prat, A., Moreno Aspitia, A., Piccart, M., Loi, S. & de Azambuja, E., Aug 30 2019, In : Breast Cancer Research and Treatment. 177, 1, p. 103-114 12 p.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Hormones
Breast Neoplasms
Disease-Free Survival
Neoplasms

Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials

Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
adjuvant P40
B 31
Trastuzumab

Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1–Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis

Iqbal, M., Reljic, T., Klocksieben, F., Sher, T., Ayala, E., Murthy, H., Bazarbachi, A., Kumar, A. & Kharfan-Dabaja, M. A., Jan 1 2019, In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Adult T Cell Leukemia Lymphoma
Cell Transplantation
Meta-Analysis
Confidence Intervals
Viruses

Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas

Iqbal, M., Roberts, A., Starr, J., Mody, K. & Kasi, P. M., Jan 1 2019, In : Journal of Gastrointestinal Oncology. 10, 3, p. 400-406 7 p.

Research output: Contribution to journalArticle

Stomach
Adenocarcinoma
Biomarkers
DNA
Stomach Neoplasms

Hypereosinophilia in a patient with metastatic non-small-cell lung cancer treated with antiprogrammed cell death 1 (anti-PD-1) therapy

Lou, Y., Marin-Acevedo, J. A., Vishnu, P., Manochakian, R., Dholaria, B., Soyano, A., Luo, Y., Zhang, Y. & Knutson, K. L., May 1 2019, In : Immunotherapy. 11, 7, p. 577-584 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Eosinophilia
Cell Death
Therapeutics
Eosinophils

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

Fang, H., Reichard, K. K., Rabe, K. G., Hanson, C. A., Call, T. G., Ding, W. D., Kenderian, S., Muchtar, E., Schwager, S. M., Leis, J. F., Chanan Khan, A. A., Slager, S. L., Braggio, E. D., Smoley, S. A., Kay, N. E., Shanafelt, T. D., Van Dyke, D. L. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Survival
Therapeutics
Databases
1 Citation (Scopus)

Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma

Jagannath, S., Heffner, L. T., Ailawadhi, S., Munshi, N. C., Zimmerman, T. M., Rosenblatt, J., Lonial, S., Chanan Khan, A. A., Ruehle, M., Rharbaoui, F., Haeder, T., Wartenberg-Demand, A. & Anderson, K. C., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Appointments and Schedules
Neoplasms

Inositol hexaphosphate plus inositol induced complete remission in stage IV melanoma: a case report

Khurana, S., Baldeo, C. & Joseph, R. W., Jun 1 2019, In : Melanoma research. 29, 3, p. 322-324 3 p.

Research output: Contribution to journalArticle

Phytic Acid
Inositol
Melanoma
Vitamin B Complex
Nuts

Intraocular involvement of Mantle cell lymphoma: A case report and literature review

Iqbal, M., Castano, Y. G., Sher, T. & Kharfan-Dabaja, M. A., Jan 1 2019, In : Hematology/ Oncology and Stem Cell Therapy.

Research output: Contribution to journalArticle

Open Access
Mantle-Cell Lymphoma
Lymphoma
Transplants
Drug Therapy
Marginal Zone B-Cell Lymphoma

Introduction of novel agents in the treatment of primary CNS lymphoma

Grommes, C., Nayak, L., Tun, H. W. & Batchelor, T. T., Jan 1 2019, In : Neuro-oncology. 21, 3, p. 306-313 8 p.

Research output: Contribution to journalArticle

Lymphoma
Central Nervous System
Clinical Trials
Phosphatidylinositol 3-Kinase
Immune Evasion
1 Citation (Scopus)

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

Kumar, S. K., Berdeja, J. G., Niesvizky, R., Lonial, S., Laubach, J. P., Hamadani, M., Stewart, A. K., Hari, P., Roy, V., Vescio, R., Kaufman, J. L., Berg, D., Liao, E., Rajkumar, S. V. & Richardson, P. G., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Maintenance
Stem Cell Transplantation
Disease-Free Survival
1 Citation (Scopus)

Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner

Picariello, H. S., Kenchappa, R. S., Rai, V., Crish, J. F., Dovas, A., Pogoda, K., McMahon, M., Bell, E. S., Chandrasekharan, U., Luu, A., West, R., Lammerding, J., Canoll, P., Odde, D. J., Janmey, P. A., Egelhoff, T. & Rosenfeld, S., Jul 30 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 31, p. 15550-15559 10 p.

Research output: Contribution to journalArticle

Open Access
Nonmuscle Myosin Type IIA
Glioblastoma
Myosin Type II
Neoplasms
Mechanics

Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013

Al-Kali, A., Zblewski, D., Foran, J. M., Patnaik, M. M., Larrabee, B. R., Gangat, N., Begna, K., Elliott, M. A., Hogan, W., Tefferi, A., Litzow, M. R. & Go, R. S., Aug 1 2019, In : Mayo Clinic proceedings. 94, 8, p. 1467-1474 8 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Databases
Neoplasms
Survival
Refractory Anemia with Excess of Blasts
1 Citation (Scopus)

Patient and Oncology Nurse Preferences for the Treatment Options in Advanced Melanoma: A Discrete Choice Experiment

Liu, F. X., Witt, E. A., Ebbinghaus, S., Dibonaventura Beyer, G., Basurto, E. & Joseph, R. W., Jan 1 2019, In : Cancer Nursing. 42, 1, p. E52-E59

Research output: Contribution to journalArticle

Melanoma
Nurses
Disease-Free Survival
Appointments and Schedules
Therapeutics
1 Citation (Scopus)

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

McDonald, B. R., Contente-Cuomo, T., Sammut, S. J., Odenheimer-Bergman, A., Ernst, B., Perdigones, N., Chin, S. F., Farooq, M., Mejia, R., Cronin, P. A., Anderson, K. S., Kosiorek, H. E., Northfelt, D. W., McCullough, A. E., Patel, B., Weitzel, J. N., Slavin, T. P., Caldas, C., Pockaj, B. A. & Murtaza, M., Aug 7 2019, In : Science translational medicine. 11, 504, eaax7392.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Breast Neoplasms
DNA
Neoplasms
Alleles

Phase II trial of eribulin in patients with metastatic hormone refractory prostate cancer: A trial of the ECOG-ACRIN cancer research group (E5805)

Stein, M. N., Chen, Y. H., Carducci, M. A., Hudes, G. R., Lerma, P. M., Tan, W., Dalune, R., Rowland, K. M., Kuzel, T. M. & Dipaola, R. S., Jan 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

eribulin
Prostatic Neoplasms
Hormones
Drug Therapy
Research
1 Citation (Scopus)

Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma

Stewart, A. K., Krishnan, A. Y., Singhal, S., Boccia, R. V., Patel, M. R., Niesvizky, R., Chanan Khan, A. A., Ailawadhi, S., Brumm, J., Mundt, K. E., Hong, K., McBride, J., Shon-Nguyen, Q., Xiao, Y., Ramakrishnan, V., Polson, A. G., Samineni, D., Leipold, D., Humke, E. W., McClellan, J. S. & 1 others, Berdeja, J. G., Feb 1 2019, In : Blood cancer journal. 9, 2, 17.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Anti-Idiotypic Antibodies
Maximum Tolerated Dose
Antibodies
Pharmaceutical Preparations

Pomalidomide alters pancreatic macrophage populations to generate an immune-responsive environment at precancerous and cancerous lesions

Bastea, L. I., Liou, G. Y., Pandey, V., Fleming, A. K., Von Roemeling, C. A., Doeppler, H., Li, Z., Qiu, Y., Edenfield, B., Copland, J. A. III., Tun, H. W. & Storz, P., Apr 1 2019, In : Cancer Research. 79, 7, p. 1535-1548 14 p.

Research output: Contribution to journalArticle

Open Access
Macrophages
Pancreatic Neoplasms
Population
Immunosuppressive Agents
Neoplasms

Potential influence of IDH1 mutation and MGMT gene promoter methylation on glioma-related preoperative seizures and postoperative seizure control

Feyissa, A. M., Worrell, G. A., Tatum, W. O., Chaichana, K. L., Jentoft, M. E., Guerrero Cazares, H., Taner, N., Rosenfeld, S., ReFaey, K. & Quinones-Hinojosa, A., Jul 1 2019, In : Seizure. 69, p. 283-289 7 p.

Research output: Contribution to journalArticle

Glioma
Methylation
Seizures
Mutation
Genes
1 Citation (Scopus)

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations

Soumerai, J. D., Ni, A., Darif, M., Londhe, A., Xing, G., Mun, Y., Kay, N. E., Shanafelt, T. D., Rabe, K. G., Byrd, J. C., Chanan Khan, A. A., Furman, R. R., Hillmen, P., Jones, J., Seymour, J. F., Sharman, J. P., Ferrante, L., Mobasher, M., Stark, T., Reddy, V. & 5 others, Dreiling, L. K., Bhargava, P., Howes, A., James, D. F. & Zelenetz, A. D., Jul 1 2019, In : The Lancet Haematology. 6, 7, p. e366-e374

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Cohort Studies
Therapeutics
Survival
Databases

Progress Toward Long-Term Survivors of Glioblastoma

Cantrell, J. N., Waddle, M. R., Rotman, M., Peterson, J. L., Ruiz-Garcia, H., Heckman, M. G., Quinones-Hinojosa, A., Rosenfeld, S., Brown, P. D. & Trifiletti, D. M., Jul 1 2019, In : Mayo Clinic proceedings. 94, 7, p. 1278-1286 9 p.

Research output: Contribution to journalArticle

Glioblastoma
Survivors
Survival
Logistic Models
Brain Stem Neoplasms
1 Citation (Scopus)

Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT

Evans, J. D., Morris, L. K., Zhang, H., Cao, S., Liu, X., Mara, K. C., Stish, B. J., Davis, B. J., Mansfield, A., Dronca, R. S., Iott, M. J., Kwon, E. D., Foote, R. L., Olivier, K. R., Dong, H. M. & Park, S. S., Jan 1 2019, In : International Journal of Radiation Oncology Biology Physics. 103, 1, p. 229-240 12 p.

Research output: Contribution to journalArticle

Immunophenotyping
metastasis
Prostatic Neoplasms
cancer
Neoplasm Metastasis
2 Citations (Scopus)

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., Rushing, D., Okuno, S. H., Reinke, D. K., Riedel, R. F., Attia, S., Mascarenhas, L. & Maki, R. G., Jun 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 16, p. 1424-1431 8 p.

Research output: Contribution to journalArticle

Osteosarcoma
Disease-Free Survival
Placebos
Sarcoma
Clinical Trials Data Monitoring Committees
1 Citation (Scopus)

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

Hampel, P. J., Ding, W. D., Call, T. G., Rabe, K. G., Kenderian, S., Witzig, T. E., Muchtar, E., Leis, J. F., Chanan Khan, A. A., Koehler, A. B., Fonder, A. L., Schwager, S. M., Slager, S. L., Shanafelt, T. D., Kay, N. E. & Parikh, S. A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Disease Progression
Clinical Trials
PCI 32765
Therapeutics
1 Citation (Scopus)

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma, N., Abdel-Ghani, A., Yadav, S., Hoversten, K. P., Reed, C. T., Sitek, A. N., Enninga, E. A. L., Paludo, J., Aguilera, J. V., Leventakos, K., Lou, Y., Kottschade, L. A., Dong, H. M., Mansfield, A., Manochakian, R., Adjei, A. & Dronca, R. S., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Programmed Cell Death 1 Receptor
Non-Small Cell Lung Carcinoma
Sex Characteristics
Melanoma
Therapeutics
2 Citations (Scopus)

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination with Pembrolizumab in Patients with Recurrent Platinum-Resistant Ovarian Carcinoma

Konstantinopoulos, P. A., Waggoner, S., Vidal, G. A., Mita, M., Moroney, J. W., Holloway, R., Van Le, L., Sachdev, J. C., Chapman-Davis, E., Colon-Otero, G., Penson, R. T., Matulonis, U. A., Kim, Y. B., Moore, K. N., Swisher, E. M., Färkkilä, A., D'Andrea, A., Stringer-Reasor, E., Wang, J., Buerstatte, N. & 5 others, Arora, S., Graham, J. R., Bobilev, D., Dezube, B. J. & Munster, P., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

Platinum
Carcinoma
Triple Negative Breast Neoplasms
pembrolizumab
niraparib

Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial

Younger, E., Ballman, K., Lu, Y., Pápai, Z., Van Tine, B. A., Attia, S., Schöffski, P., Reinke, D., Tap, W. D. & Jones, R. L., Jan 1 2019, In : Journal of Geriatric Oncology.

Research output: Contribution to journalArticle

Open Access
Doxorubicin
Anthracyclines
Sarcoma
TH 302
Drug Therapy

Survival trends in glioblastoma and association with treating facility volume

Aulakh, S., DeDeo, M. R., Free, J., Rosenfeld, S., Quinones-Hinojosa, A., Paulus, A., Manna, A., Manochakian, R., Chanan Khan, A. A. & Ailawadhi, S., Jan 1 2019, In : Journal of Clinical Neuroscience.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Survival
Therapeutics
Neoplasms

Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities

Ailawadhi, S., Azzouqa, A. G., Hodge, D., Cochuyt, J., Jani, P., Ahmed, S., Sher, T., Roy, V., Ailawadhi, M., Alegria, V. R., Manochakian, R., Vishnu, P., Grover, A., Abdulazeez, M. F., Paulus, A. & Chanan Khan, A. A., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Survival
Survival Rate
Hispanic Americans
Epidemiology
1 Citation (Scopus)

Targeting CD38 enhances the antileukemic activity of ibrutinib in chronic lymphocytic leukemia

Manna, A., Aulakh, S., Jani, P., Ahmed, S., Akhtar, S., Coignet, M., Heckman, M., Meghji, Z., Bhatia, K., Sharma, A., Sher, T., Alegria, V., Malavasi, F., Chini, E. N., Chanan Khan, A. A., Ailawadhi, S. & Paulus, A., Jan 1 2019, In : Clinical Cancer Research. 25, 13, p. 3974-3985 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Heterografts
B-Lymphocytes
Antibody-Dependent Cell Cytotoxicity
PCI 32765
1 Citation (Scopus)

The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes

Sekeres, M. A., Gore, S. D., Stablein, D. M., DiFronzo, N., Abel, G. A., DeZern, A. E., Troy, J. D., Rollison, D. E., Thomas, J. W., Waclawiw, M. A., Liu, J. J., Al Baghdadi, T., Walter, M. J., Bejar, R., Gorak, E. J., Starczynowski, D. T., Foran, J. M., Cerhan, J. R., Moscinski, L. C., Komrokji, R. S. & 2 others, Deeg, H. J. & Epling-Burnette, P. K., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Natural History
Research
Hematopoietic Stem Cells
National Heart, Lung, and Blood Institute (U.S.)
2018
7 Citations (Scopus)

Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy

von Roemeling, C. A., Caulfield, T., Marlow, L., Bok, I., Wen, J., Miller, J. L., Hughes, R., Hazlehurst, L., Pinkerton, A. B., Radisky, D. C., Tun, H. W., Kim, Y. S. B., Lane, A. L. & Copland, J. A. III., Jan 1 2018, In : Oncotarget. 9, 1, p. 3-20 18 p.

Research output: Contribution to journalArticle

Stearoyl-CoA Desaturase
Drug Design
Enzyme Inhibitors
Drug Discovery
Toxicology
40 Citations (Scopus)

Alcohol and cancer: A statement of the American society of clinical oncology

LoConte, N. K., Brewster, A. M., Kaur, J. S., Merrill, J. K. & Alberg, A. J., Jan 1 2018, In : Journal of Clinical Oncology. 36, 1, p. 83-93 11 p.

Research output: Contribution to journalArticle

Medical Oncology
Alcohols
Neoplasms
Alcohol Drinking
Education

Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience

Dholaria, B. R., Hammond, W. A., Roy, V., Sher, T., Vishnu, P., Soyano, A., Finn, L. E. & Tun, H. W., Mar 23 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle

Lymphoma
Transplants
7 Citations (Scopus)
Primary Myelofibrosis
Hematopoietic Stem Cells
Karyotype
Transplants
Survival

AlternativeOutpatientChemotherapy scheduling method to improve patient service quality and nurse satisfaction

Huang, Y. L., Bryce, A. H., Culbertson, T., Connor, S. L., Looker, S. A., Altman, K. M., Collins, J. G., Stellner, W., Mc Williams, R. R., Moreno Aspitia, A., Ailawadhi, S. & Mesa, R. A., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. e82-e91

Research output: Contribution to journalArticle

Nurses
Workload
Safety
Drug Therapy
Nursing Staff
6 Citations (Scopus)

A phase i clinical trial of the Poly(ADP-ribose) polymerase inhibitor veliparib and weekly topotecan in patients with solid tumors

Wahner Hendrickson, A. E., Menefee, M. E., Hartmann, L. C., Long, H. J., Northfelt, D. W., Reid, J. M., Boakye-Agyeman, F., Kayode, O., Flatten, K. S., Harrell, M. I., Swisher, E. M., Poirer, G. G., Satele, D., Allred, J., Lensing, J. L., Chen, A., Ji, J., Zang, Y., Erlichman, C., Haluska, P. & 1 others, Kaufmann, S. H., Feb 15 2018, In : Clinical Cancer Research. 24, 4, p. 744-752 9 p.

Research output: Contribution to journalArticle

Topotecan
Clinical Trials
Neoplasms
Maximum Tolerated Dose
Mutation
1 Citation (Scopus)

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma

Ailawadhi, S., Kelly, K. R., Vescio, R. A., Jagannath, S., Wolf, J., Gharibo, M., Sher, T., Bojanini, L., Kirby, M. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Pharmacokinetics
Safety
Maximum Tolerated Dose
Clinical Trials, Phase I
6 Citations (Scopus)

A posttranslational modification of the mitotic kinesin Eg5 that enhances its mechanochemical coupling and alters its mitotic function

Muretta, J. M., Reddy, B. J. N., Scarabelli, G., Thompson, A. F., Jariwala, S., Major, J., Venere, M., Rich, J. N., Willard, B., Thomas, D. D., Stumpff, J., Grant, B. J., Gross, S. P. & Rosenfeld, S., Feb 20 2018, In : Proceedings of the National Academy of Sciences of the United States of America. 115, 8, p. E1779-E1788

Research output: Contribution to journalArticle

Kinesin
Post Translational Protein Processing
Lysine
Acetylation
Mechanics